Global Fund Strategy (2023-2028): Fighting Pandemics and Building a Healthier and More Equitable World was approved at the 46th Board Meeting. It sets out how the Global Fund partnership aims to accelerate impact towards the 2030 horizon and contribute to a world free of the burden of AIDS, tuberculosis and malaria, with better, more equitable health for all.
The Strategy publication will be available in December.
The Strategy was developed through a highly consultative two-year process, guided by the Global Fund Strategy Committee and Board, and by input and evidence provided by Global Fund partners, including through the Open Consultation on Strategy Development, and the 6th Partnership Forums. The wealth of recommendations and perspectives collected throughout the Strategy development process were used to develop the Strategy Framework, which was approved by the Global Fund Board in July 2021, and then the Strategy Narrative [ download in English | Français ] , which was approved at the 46th Board Meeting in November 2021.
The new Strategy is prioritized, maintains ending AIDS, TB and malaria as the Global Fund’s primary goal, and puts people and communities at the center of all our work.
Achievement of the Strategy’s primary goal to end AIDS, TB and malaria is underpinned by four mutually reinforcing contributory objectives that leverage the core strengths and comparative advantages of the Global Fund’s unique partnership: Maximizing People-centered Integrated Systems for Health to Deliver Impact, Resilience and Sustainability, with integrated, people-centered systems for health at their core; Maximizing the Engagement and Leadership of Most Affected Communities to Leave No One Behind; Maximizing Health Equity, Gender Equality and Human Rights; and Mobilizing Increased Resources. Each of these individual objectives is vital to accelerate impact against the three diseases, and by supporting all four areas together the Global Fund will catalyze system- and society-wide impact that is greater than the sum of its parts.
The new Strategy responds directly to the dramatic changes in the global health context by introducing an evolving objective on pandemic preparedness and response (PPR), to bring the Global Fund partnership’s expertise and inclusive model to this new imperative, and in doing so, help protect progress on HIV, TB and malaria. This PPR objective enables the Global Fund to play its part alongside partners, in the global response to COVID-19, to strengthen the resilience of systems for health and HIV, TB and malaria programs to pandemic threats, to support countries and communities to prevent, detect and respond to new pathogens of pandemic potential, and to address the multifaceted threats to health arising from climate change.
Delivery of this Strategy will depend on each player in the Global Fund’s extraordinary partnership playing their distinct and complementary part. The success of the Global Fund model is based on the principles of country ownership and partnership. The Partnership Enablers section in the new Strategy lays out explicit roles and accountabilities for every partner to ensure clarity and shared responsibility for our collective success. The Strategy also highlights where we must change the way we work and strengthen our collaboration to maximize impact and accelerate the pace of implementation.
With the Strategy now approved, preparations are starting to be made for its implementation, including the development of the Monitoring & Evaluation (M&E) Framework and Key Performance Indicators (KPIs) to measure the performance of the next Strategy, and preparations for the next cycle of grants. The Strategy’s approval will also inform preparations for the Seventh Replenishment in 2022.